Ryan Dinwiddie

Ryan Dinwiddie

Ask VT AI

View News Summary

Novo Nordisk launches a rival $56.50 bid to acquire U.S. obesity biotech Metsera, challenging Pfizer's existing agreement and sparking a bidding war over Metsera's promising GLP-1 pipeline.
Trump boasts about passing a dementia test, mocking Democrats, but experts say the test is not proof of superior intelligence.
Drake Maye emerges as a legitimate MVP contender with his impressive performance for the New England Patriots.

20 days

United States Politics

Discover the latest news, candidates,  and key topics of US politics

Ask VT AI

View News Summary

Novo Nordisk launches a rival $56.50 bid to acquire U.S. obesity biotech Metsera, challenging Pfizer's existing agreement and sparking a bidding war over Metsera's promising GLP-1 pipeline.
Trump boasts about passing a dementia test, mocking Democrats, but experts say the test is not proof of superior intelligence.
Drake Maye emerges as a legitimate MVP contender with his impressive performance for the New England Patriots.

20 days

United States Politics

Discover the latest news, candidates,  and key topics of US politics

Most Reported By
News from Ryan Dinwiddie